AXSM
Axsome Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AXSM fundamentals
Axsome Therapeutics (AXSM) released its earnings on Nov 3, 2025: revenue was 171.00M (YoY +64.84%), beat estimates; EPS was -0.95 (YoY +29.10%), missed estimates.
Revenue / YoY
171.00M
+64.84%
EPS / YoY
-0.95
+29.10%
Report date
Nov 3, 2025
AXSM Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 2025 revenue of $171 million (+63% YoY), driven by AUVELITY (+69% YoY), SUNOSI (+35% YoY), and SYMBRAVO launch.
- Pipeline Momentum: AXS-05 (Alzheimer's agitation) NDA submission, AXS-12 narcolepsy NDA expected in Q4, and AXS-14 fibromyalgia Phase III trial initiation.
- Commercial Strength: AUVELITY with 46,000 prescribers and 85% payer coverage, SYMBRAVO with 5,000+ prescriptions in first quarter.
- Financial Health: Net loss of $47.2 million (-28% YoY), $325 million cash, and plans for cash flow positivity.
EPS
Revenue
Revenue & Expenses
AXSM has released its 2025 Q3 earnings report, with revenue of 170.99M, reflecting a YoY change of 63.22%, and net profit of -47.23M, showing a YoY change of 26.89%. The Sankey diagram below clearly presents AXSM's revenue sources and cost distribution.
Key Indicators
Axsome Therapeutics (AXSM) key financial stats and ratios, covering profitability, financial health, and leverage.
Axsome Therapeutics (AXSM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Axsome Therapeutics (AXSM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Axsome Therapeutics (AXSM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Axsome Therapeutics (AXSM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Axsome Therapeutics (AXSM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Axsome Therapeutics's revenue and profit?What is the market's earnings forecast for Axsome Therapeutics next quarter?Did Axsome Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Axsome Therapeutics’s earnings call?What is Axsome Therapeutics's gross profit margin?What guidance did Axsome Therapeutics's management provide for the next earnings period?What were the key takeaways from Axsome Therapeutics's earnings call?What is Axsome Therapeutics's latest dividend and current dividend yield?
